56 related articles for article (PubMed ID: 8657075)
1. [Determination of radiochemical purity of 99mTc(Sn)-methylene diphosphonate using gel chromatography].
Vucina JL
Med Pregl; 1995; 48(3-4):95-7. PubMed ID: 8657075
[TBL] [Abstract][Full Text] [Related]
2. 99mTc bone scanning agents--III. Preparation and gel chromatography of 99mTc(Sn)MDP complexes.
Kroesbergen J; Gelsema WJ; de Ligny CL
Int J Nucl Med Biol; 1986; 12(6):419-24. PubMed ID: 3710704
[TBL] [Abstract][Full Text] [Related]
3. [The effect of contaminants on characteristics of 99mTC radiopharmaceuticals].
Vucina J; Vuga D; Maksin T; Vanlić-Razumenić N
Med Pregl; 1994; 47(9-10):320-2. PubMed ID: 7565319
[TBL] [Abstract][Full Text] [Related]
4. Reversed-phase HPLC of 99mTc methylene diphosphonate bone imaging kits with quantification of pertechnetate.
Hoch DJ; Pinkerton TC
Int J Rad Appl Instrum A; 1986; 37(7):593-8. PubMed ID: 3021661
[TBL] [Abstract][Full Text] [Related]
5. 99mTc bone scanning agents--V. Influence of experimental conditions on the labeling efficiency and gel chromatography of 99mTc(Sn)HMDP.
Kroesbergen J; Wortelboer MR; Rijnsent A; Gelsema WJ; de Ligny CL
Int J Rad Appl Instrum B; 1987; 14(1):37-41. PubMed ID: 3583753
[TBL] [Abstract][Full Text] [Related]
6. Determination of the radiochemical purity of (99m) Tc medronate injection by thin layer chromatography on iTLC-SG: effect of medronate concentration on the value measured.
Cunnane CM; O'Brien LM; Waight LA; Millar AM
J Labelled Comp Radiopharm; 2013 May; 56(5):301-4. PubMed ID: 24285375
[TBL] [Abstract][Full Text] [Related]
7. A comparative investigation of the gel chromatography column scanning method for quality control of 99mTc-methylenediphosphonate.
Darte L
Nuklearmedizin; 1981 Apr; 20(2):51-63. PubMed ID: 6454114
[TBL] [Abstract][Full Text] [Related]
8. Determination of radiochemical purity and pharmacokinetic parameters of 99mTc-sulphur colloid and 99mTc-tin colloid.
Jovanović V; Konstantinovska D; Milivojević K; Bzenić J
Nuklearmedizin; 1981 Dec; 20(6):279-82. PubMed ID: 7329810
[TBL] [Abstract][Full Text] [Related]
9. Electrolytically labeled [99mTc]MDP: chromatographic pattern, stability and biodistribution in rats.
Savelkoul TJ; Oldenburg SJ; Van Oort WJ; Duursma SA
Int J Appl Radiat Isot; 1984 Aug; 35(8):709-13. PubMed ID: 6237064
[TBL] [Abstract][Full Text] [Related]
10. [Radiochemical purity and stability of Tc-99m-pyrophosphate].
Vucina J
Med Pregl; 2000; 53(9-10):502-5. PubMed ID: 11320732
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of five miniature chromatography systems for determining labeling efficiency of technetium Tc 99m pentetate.
Robbins PJ
Am J Hosp Pharm; 1983 Apr; 40(4):629-33. PubMed ID: 6342380
[TBL] [Abstract][Full Text] [Related]
12. Comparative quality control of 99mTc-Pyrophosphate and 99mTc-diphosphonate radiopharmaceuticals.
Jovanović V; Maksin T; Rastovac M; Bzenić J
Eur J Nucl Med; 1983; 8(4):179-82. PubMed ID: 6861787
[TBL] [Abstract][Full Text] [Related]
13. Antecedent 99mTc-MDP and 99mTc-sestamibi administration corrupts bone mineral density measured by DXA.
McKiernan FE; Hocking J; Cournoyer S
J Clin Densitom; 2006; 9(2):164-6. PubMed ID: 16785076
[TBL] [Abstract][Full Text] [Related]
14. The adsorption of 99mTc(Sn)-diphosphonate complexes on tri-calciumphosphate: the influence of preparation conditions, ligand-type, incubation media and adsorption conditions. The reversibility of the adsorption.
Huigen YM; Krips HJ; Hulleman S; Gelsema WJ; De Ligny CL
Int J Rad Appl Instrum A; 1990; 41(2):189-94. PubMed ID: 2158946
[TBL] [Abstract][Full Text] [Related]
15. [Stabilization of 99m Tc-HMPAO with methylene blue: its use in leukocyte labelling)].
García Seguí V; Roca Engroñat M; Armero Muñoz F; Iglesias Allende F; Gomes Barreto de Mélo V; Martin-Comín J
Rev Esp Med Nucl; 1998; 17(4):261-4. PubMed ID: 9721341
[TBL] [Abstract][Full Text] [Related]
16. The binding of 99mTc(Sn)-MDP complexes to human serum albumin and other blood proteins determined with gel chromatography and ultrafiltration.
Huigen YM; Tji TG; Gelsema WJ; de Ligny CL
Int J Rad Appl Instrum A; 1989; 40(7):629-35. PubMed ID: 2551860
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of 99mTc-tin-methylene diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.
Coupal JJ
Calcif Tissue Int; 1981; 33(5):555. PubMed ID: 6797708
[No Abstract] [Full Text] [Related]
18. Protein-binding and urinary excretion of 99mTc(Sn)-MDP and 99mTc-MDP.
Savelkoul TJ; van Ginkel JJ; Grouls RJ; Oldenburg SJ; Duursma SA
Int J Nucl Med Biol; 1985; 12(2):125-31. PubMed ID: 4044141
[TBL] [Abstract][Full Text] [Related]
19. 99mTc bone scanning agents--VI. Gel chromatographic analysis of the plasma protein binding of 99mTc(Sn)pyrophosphate, 99mTc(Sn)MDP and 99mTc(Sn)HMDP.
Kroesbergen J; Roozen AM; Wortelboer MR; Gelsema WJ; de Ligny CL
Int J Rad Appl Instrum B; 1988; 15(5):479-87. PubMed ID: 3254872
[No Abstract] [Full Text] [Related]
20. Effect of solvent flow rate in mini-column testing of 99mTc-mertiatide.
Ponto JA
J Nucl Med Technol; 2005 Dec; 33(4):232-3. PubMed ID: 16322124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
